BURCON NUTRASCIENCE CORP (BU.CA) Stock Price, Quote, News and Overview
TSX:BU - Toronto Stock Exchange - CA1208311029 - Common Stock - Currency: CAD
BU.CA Quote, Performance and Key Statistics
TSX:BU (8/5/2025, 7:00:00 PM)
2.88
+0.03 (+1.05%)
The current stock price of BU.CA is 2.88 CAD. In the past month the price decreased by -4%. In the past year, price decreased by -26.15%.
BU.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| AIM-PR-C.CA | AIMIA INC - AIMCN 7.773 PERP | N/A | 1.87B | ||
| AIM-PR-A.CA | AIMIA INC - AIMCN 4.802 PERP | N/A | 1.81B | ||
| VNP.CA | 5N PLUS INC | 28.33 | 1.29B | ||
| NEO.CA | NEO PERFORMANCE MATERIALS IN | N/A | 692.96M | ||
| AIM.CA | AIMIA INC | N/A | 290.78M | ||
| ECO.CA | ECOSYNTHETIX INC | N/A | 243.69M | ||
| BPYP-PR-A.CA | Brookfield Property Preferred LP | N/A | 160.45M | ||
| NANO.CA | NANO ONE MATERIALS CORP | N/A | 107.04M | ||
| HPQ.CA | HPQ SILICON INC | N/A | 63.29M | ||
| AUUA.CA | ALUULA COMPOSITES INC | N/A | 22.55M |
Related stock screener links
About BU.CA
Company Profile
Burcon NutraScience Corp. engages in the development of plant proteins and ingredients for use in the food and beverage industries. The company is headquartered in Vancouver, British Columbia. The firm has an extensive patent portfolio covering its novel plant-based proteins derived from pea, canola, soy, hemp and sunflower seeds, among other plant sources. The company is engaged in the production of hemp protein isolate and the provision of contract research services. Its products include hempseed protein, canola protein, pea proteins and protein blends. Its hempseed protein isolate extraction and purification/production process can produce a high-quality protein ingredient that contains 95% pure protein. The company extracts and purifies a canola protein isolate from canola meal. The company has branded this protein isolate under the trade name Puratein C. It provides consulting and contract services, product and process development, and process scale-up and validation. The company also operates a protein production facility located in Galesburg, Illinois.
Company Info
BURCON NUTRASCIENCE CORP
1946 Broadway W
Vancouver BRITISH COLUMBIA V6J 1Z2 CA
CEO: Johann F. Tergesen
Employees: 25
Phone: 16047330896
BURCON NUTRASCIENCE CORP / BU.CA FAQ
What is the stock price of BURCON NUTRASCIENCE CORP today?
The current stock price of BU.CA is 2.88 CAD. The price increased by 1.05% in the last trading session.
What is the ticker symbol for BURCON NUTRASCIENCE CORP stock?
The exchange symbol of BURCON NUTRASCIENCE CORP is BU and it is listed on the Toronto Stock Exchange exchange.
On which exchange is BU.CA stock listed?
BU.CA stock is listed on the Toronto Stock Exchange exchange.
What is BURCON NUTRASCIENCE CORP worth?
BURCON NUTRASCIENCE CORP (BU.CA) has a market capitalization of 36.55M CAD. This makes BU.CA a Nano Cap stock.
How many employees does BURCON NUTRASCIENCE CORP have?
BURCON NUTRASCIENCE CORP (BU.CA) currently has 25 employees.
What are the support and resistance levels for BURCON NUTRASCIENCE CORP (BU.CA) stock?
BURCON NUTRASCIENCE CORP (BU.CA) has a support level at 2.67 and a resistance level at 2.89. Check the full technical report for a detailed analysis of BU.CA support and resistance levels.
Is BURCON NUTRASCIENCE CORP (BU.CA) expected to grow?
The Revenue of BURCON NUTRASCIENCE CORP (BU.CA) is expected to grow by 153.85% in the next year. Check the estimates tab for more information on the BU.CA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BURCON NUTRASCIENCE CORP (BU.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BU.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BU.CA, evaluating the profitability, health, valuation and growth aspects
- BURCON NUTRASCIENCE CORP (BU.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BURCON NUTRASCIENCE CORP (BU.CA) Sales and EPS estimates to see what analysts future expectations are.
- BURCON NUTRASCIENCE CORP (BU.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BURCON NUTRASCIENCE CORP (BU.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- BURCON NUTRASCIENCE CORP (BU.CA) Stock Chart to make your own analysis
- BURCON NUTRASCIENCE CORP (BU.CA) Latest news and press-releases to stay up to date.
Does BURCON NUTRASCIENCE CORP (BU.CA) stock pay dividends?
BU.CA does not pay a dividend.
When does BURCON NUTRASCIENCE CORP (BU.CA) report earnings?
BURCON NUTRASCIENCE CORP (BU.CA) will report earnings on 2025-08-12.
What is the Price/Earnings (PE) ratio of BURCON NUTRASCIENCE CORP (BU.CA)?
BURCON NUTRASCIENCE CORP (BU.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.77).
BU.CA Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to BU.CA. When comparing the yearly performance of all stocks, BU.CA turns out to be only a medium performer in the overall market: it outperformed 50.02% of all stocks.
BU.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BU.CA. BU.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
BU.CA Financial Highlights
Over the last trailing twelve months BU.CA reported a non-GAAP Earnings per Share(EPS) of -0.77. The EPS decreased by -1323.48% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.96% | ||
| ROE | -119.03% | ||
| Debt/Equity | 2.8 |
BU.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to BU.CA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 143.99% and a revenue growth 153.85% for BU.CA